In a report released yesterday, Travis Steed from Bank of America Securities maintained a Buy rating on Dexcom. The company’s shares closed yesterday at $82.52. Steed covers the Healthcare sector, ...
DexCom, Inc. (DXCM) is a San Diego, California-headquartered medical technology company that develops, manufactures, and ...
DexCom, Inc. (Nasdaq: DXCM), a global leader in continuous glucose monitoring, today officially opened its state-of-the-art ...
DexCom Inc., a maker of monitoring devices for diabetes patients, cut its full-year sales outlook on Thursday — a move that surprised some analysts and investors and sent its stock tumbling after ...
DexCom (NASDAQ:DXCM) expects a record number of new patients in 2026 and is preparing for a potential expansion of Medicare ...
Dexcom's first European manufacturing plant has officially opened in Athenry, Galway and will be part of the companies EMEA strategy.
April 30 (Reuters) - Medical device maker Dexcom on Thursday reiterated its full-year revenue forecast after beating Wall Street estimates for quarterly results, helped by strong demand for its ...
Medical Device Network on MSN
Dexcom lifts 2026 revenue outlook after positive Q3
Dexcom now expects 2026 revenues to land in the $5.2bn to $5.25bn range, up from $5.18bn at the low-end as previously outlined.
DexCom treats about 2.5 million patients, with tons of room for more. The company's Q2 guidance bombshell tanked the stock. Competition from an unexpected source raises long-term concerns worth ...
Dexcom G7 15 Day arrives in Canada in November with longer sensor wear and expanded insurance coverage. Here's what users should know before switching.
DexCom, Inc. officially opened its manufacturing facility in Athenry, County Galway, marking a major milestone in the company ...
Dexcom stock enters a key expansion phase as the company expects record new patients in 2026. Broader Medicare coverage could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results